Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $64.87 USD
Change Today +0.62 / 0.96%
Volume 201.0K
CYBX On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

cyberonics inc (CYBX) Snapshot

Open
$64.17
Previous Close
$64.25
Day High
$64.97
Day Low
$64.10
52 Week High
02/26/15 - $76.48
52 Week Low
11/20/14 - $48.19
Market Cap
1.7B
Average Volume 10 Days
390.8K
EPS TTM
$2.45
Shares Outstanding
26.0M
EX-Date
--
P/E TM
26.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for CYBERONICS INC (CYBX)

cyberonics inc (CYBX) Related Bloomberg News

View More Bloomberg News

cyberonics inc (CYBX) Related Businessweek News

No Related Businessweek News Found

cyberonics inc (CYBX) Details

Cyberonics, Inc., together with its subsidiaries, designs, develops, markets, and sells implantable medical devices to hospitals and ambulatory surgery centers. The company offers vagus nerve stimulation (VNS) therapy system that uses pulsed electrical signals applied to the vagus nerve for the treatment of refractory epilepsy and treatment-resistant depression. It is also engaged in investigating the use of VNS and other neuromodulation therapy for other indications, including chronic heart failure, and developing non-implantable device solutions for the management of epilepsy. The company sells its products directly, as well as through independent distributors in Europe, Canada, Mexico, Australia, parts of Central and South America, the Middle East, China, Japan, and other parts of Asia. Cyberonics, Inc. was founded in 1987 and is headquartered in Houston, Texas.

639 Employees
Last Reported Date: 06/16/14
Founded in 1987

cyberonics inc (CYBX) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: $613.7K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $334.1K
Chief Operating Officer and Senior Vice Presi...
Total Annual Compensation: $186.6K
Chief Administrative Officer, Senior Vice Pre...
Total Annual Compensation: $318.1K
Vice President of Emerging Therapy
Total Annual Compensation: $100.4K
Compensation as of Fiscal Year 2014.

cyberonics inc (CYBX) Key Developments

Cyberonics Inc. Presents at Barclays Global Healthcare Conference, Mar-11-2015 01:05 PM

Cyberonics Inc. Presents at Barclays Global Healthcare Conference, Mar-11-2015 01:05 PM. Venue: Loews Miami Beach Hotel, 1601 Collins Avenue, Miami, Florida, United States. Speakers: Daniel Jeffrey Moore, Chief Executive Officer, President and Executive Director.

Cyberonics Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended January 23, 2015; Reaffirms Earnings Guidance for the Full Fiscal 2015

Cyberonics Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended January 23, 2015. For the quarter, the company reported net sales of $72,065,231 compared to $68,191,414 a year ago. Income from operations was $23,666,444 compared to $21,102,050 a year ago. Income before income taxes was $23,920,349 compared to $21,106,214 a year ago. Income tax expense was $7,378,889 compared to $7,206,351 a year ago. Net income was $16,541,460 or $0.62 per diluted share, compared to $13,899,863 or $0.51 per diluted share, a year ago. For the year to date, the company reported net sales of $217,486,391 compared to $207,164,890 a year ago. Income from operations was $71,931,358 compared to $56,593,730 a year ago. Income before income taxes was $72,430,417 compared to $56,515,344 a year ago. Income tax expense was $25,096,945 compared to $20,053,093 a year ago. Net income was $47,333,472 or $1.32 per diluted share, compared to $36,462,251 or $1.77 per diluted share, a year ago. Net cash provided by operating activities was $63,501,626 compared to $37,748,283 a year ago. Purchases of property, plant and equipment were $5,489,521 compared to $12,960,959 a year ago. The company reaffirmed earnings guidance for the full fiscal 2015. The company is reaffirming the fiscal 2015 guidance provided in its earnings release dated November 20, 2014, despite the significant currency headwinds affecting international sales, except as noted below. Operating income, net income and earnings per share in fiscal 2015 will be impacted by the transaction costs related to the expected merger with Sorin S.p.A.

Cyberonics Inc. to Report Q3, 2015 Results on Feb 26, 2015

Cyberonics Inc. announced that they will report Q3, 2015 results at 8:00 AM, US Eastern Standard Time on Feb 26, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYBX:US $64.87 USD +0.62

CYBX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AngioDynamics Inc $17.61 USD +0.05
ICU Medical Inc $92.27 USD +1.29
Masimo Corp $31.84 USD +0.42
Thoratec Corp $41.00 USD +0.96
Wright Medical Group Inc $25.61 USD -0.08
View Industry Companies
 

Industry Analysis

CYBX

Industry Average

Valuation CYBX Industry Range
Price/Earnings 26.5x
Price/Sales 5.8x
Price/Book 6.3x
Price/Cash Flow 25.7x
TEV/Sales 5.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYBERONICS INC, please visit www.cyberonics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.